FDA FDA 510(k) clearance: ECMT-100 WMD — K253521, Jun 18, 2026. Applicant at approval: Ecm Therapeutics, Inc. source ↗
Trial start Not phased (device or behavioral study): Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas source ↗
Upcoming milestones
Feb 24, 2027 (ESTIMATED) · Not phased · Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas · NCT07035925
Estimated primary completion per ClinicalTrials.gov. Dates move.
